Gene therapy for neurotransmitter‐related disorders
Journal of Inherited Metabolic Disease · 2024-01 · 47 (1) · 176-191
DOI: 10.1002/jimd.12697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 14.01.2024. Verfasst von Wing Sum Chu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gene Transfer Technology Group, EGA Institute for Women's Health, University College London, London, UK. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Parkinson Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Great Ormond Street Hospital Charity.
Abstract (Originalsprache)
Inborn errors of neurotransmitter (NT) metabolism are a group of rare, heterogenous diseases with predominant neurological features, such as movement disorders, autonomic dysfunction, and developmental delay. Clinical overlap with other disorders has led to delayed diagnosis and treatment, and some conditions are refractory to oral pharmacotherapies. Gene therapies have been developed and translated to clinics for paediatric inborn errors of metabolism, with 38 interventional clinical trials ongoing to date. Furthermore, efforts in restoring dopamine synthesis and neurotransmission through viral gene therapy have been developed for Parkinson's disease. Along with the recent European Medicines Agency (EMA) and Medicines and Healthcare Products Regulatory Agency (MHRA) approval of an AAV2 gene supplementation therapy for AADC deficiency, promising efficacy and safety profiles can be achieved in this group of diseases. In this review, we present preclinical and clinical advances to address NT‐related diseases, and summarise potential challenges that require careful considerations for NT gene therapy studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Transfer Technology Group, EGA Institute for Women's Health, University College London, London, UK.
- Genetic Therapy Accelerator Centre, Queen Square Institute of Neurology, University College London, London, UK.
- Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, Great Ormond Street Institute of Child Health, University College London, London, UK.
- Department of Neurology, Great Ormond Street Hospital for Children, London, UK.
ORCID-Profile: Wing Sum Chu, Joanne Ng, Simon N Waddington, Manju A Kurian
Förderung
- Wellcome Trust
- Medical Research Council
- Great Ormond Street Hospital Charity
- LifeArc
- National Institute for Health and Care Research
- Rosetrees Trust
- Sir Jules Thorn Charitable Trust
Zitieren
APA
Chu, W. S., Ng, J., Waddington, S. N., & Kurian, M. A. (2024). Gene therapy for neurotransmitter‐related disorders. Journal of Inherited Metabolic Disease, 47(1), 176-191. https://doi.org/10.1002/jimd.12697
Vancouver
Chu WS, Ng J, Waddington SN, Kurian MA. Gene therapy for neurotransmitter‐related disorders. Journal of Inherited Metabolic Disease. 2024;47(1):176-191. doi:10.1002/jimd.12697
BibTeX
@article{Chu2024,
author = {Chu, Wing Sum and Ng, Joanne and Waddington, Simon N and Kurian, Manju A},
title = {Gene therapy for neurotransmitter‐related disorders},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
volume = {47},
number = {1},
pages = {176--191},
doi = {10.1002/jimd.12697}
}
EUVIMED